1. 91O A multi-center phase IIa trial to assess the safety and efficacy of BL-8040 (a CXCR4 inhibitor) in combination with pembrolizumab and chemotherapy in patients with metastatic pancreatic adenocarcinoma (PDAC). (15th December 2019) Authors: Hidalgo, M; Semenisty, V; Bockorny, B; Borazanci, E; von Hoff, D D; Feliu, J; Sarvise, M Ponz; Abad, D Gutierrez; Peled, A; Bohana-Kashtan, O; Gozlan, Y; Sorani, E; Chaney, M; Kadosh, S; Vainstein, A V; Macarulla, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial. Issue 6 (May 2017) Authors: Pineda, Estela; Salud, A; Vila-Navarro, E; Safont, MJ; Llorente, Beatriz; Aparicio, J; Vera, R; Escudero, P; Casado, E; Bosch, C; Bohn, U; Pérez-Carrión, R; Carmona, A; Ayuso, JR; Ripollés, T; Bouzas, R; Gironella, M; García-Albéniz, X; Feliu, J; Maurel, J Journal: Tumor biology Issue: Volume 39:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-098TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441). (2nd July 2019) Authors: Hammel, P; Feliu, J; Parner, V; Berardi, R; Van Cutsem, E; Greil, R; Wasan, H; Metges, J; Nygren, P; Osterlund, P; Seufferlein, T; Creemers, G; Biswas-Baldwin, N; Youssoufian, H; Gupta, A; Salesse, S; Dion, H; El-Hariry, I; Hidalgo, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-163Whole-exome sequencing of non-metastatic anal squamous cell carcinoma: a prognostic genetic variants analysis. (2nd July 2019) Authors: Ghanem, I; Trilla, L; Gámez, A; Mendiola, M; Maurel, J; Campos-Barros, à; Peña, C; Cuatrecasas, M; G-Pastrián, L; García Alfonso, P; Feliu, J; Fresno, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P-183A pilot trial of PEGPH20 (Pegvorhyaluronidase alfa) in combination with avelumab (anti-PD-L1 MSB0010718C) in chemotherapy resistant pancreatic cancer (PDAC) - Trial in progress. (20th June 2018) Authors: Rodriguez, L Medina; Guillén-Ponce, C; Feliu, J; Hidalgo, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-183A pilot trial of PEGPH20 (Pegvorhyaluronidase alfa) in combination with avelumab (anti-PD-L1 MSB0010718C) in chemotherapy resistant pancreatic cancer (PDAC) - Trial in progress. (20th June 2018) Authors: Rodriguez, L Medina; Guillén-Ponce, C; Feliu, J; Hidalgo, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-202Search for new predictive/prognostic biomarkers in potentially resectable pancreatic ductal adenocarcinoma. (2nd July 2019) Authors: González Borja, I; Viudez, A; Goñi, S; Pérez Sanz, J; Santamaria, E; López-López, C; Pazo, R; Fonseca, P Jimenez; Arévalo, S; Feliu, J; Fernández Irigoyen, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-236Clinical and pathological features in colorectal cancer associated to Lynch syndrome. (20th June 2018) Authors: Higuera, O; Rodriguez, A; Rodriguez-Salas, N; Ruiz-Giménez, L; Gallego, A; Ghanem, I; Custodio, A; Sanchez, D; Ostios, L; Poma, J Miranda; Feliu, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-236Clinical and pathological features in colorectal cancer associated to Lynch syndrome. (20th June 2018) Authors: Higuera, O; Rodriguez, A; Rodriguez-Salas, N; Ruiz-Giménez, L; Gallego, A; Ghanem, I; Custodio, A; Sanchez, D; Ostios, L; Poma, J Miranda; Feliu, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-276Raltitrexed as salvage therapy for metastatic colorectal cancer: A multicenter retrospective study. (20th June 2018) Authors: Ghanem, I; Viudez, A; García-Torralba, E; Torres-Tenor, J; Carmona, A; Vera, R; Rodriguez-Salas, N; de la Peña, F Ayala; Higuera, O; Feliu, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗